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Background
Selective digestive tract decontamination (SDD) and selective oropharyngeal decontamination (SOD) are infection-
prevention measures used in the treatment of some patients in intensive care, but reported eff ects on patient 
outcome are confl icting.
Methods
Objective: To evaluate the eff ectiveness of SDD and SOD in intensive care unit (ICU) patients.
Design: A controlled, crossover study using cluster randomization.
Setting: 13 ICUs in the Netherlands between May 2004 and July 2006.
Subjects: 5939 patients with an expected duration of intubation of more than 48 hours or an expected ICU stay of 
more than 72 hours were eligible.
Intervention: In each ICU, three regimens (SDD, SOD, and standard care) were applied in random order over the 
course of 6 months. SDD consisted of 4 days of intravenous cefotaxime and topical application of tobramycin, colistin, 
and amphotericin B in the oropharynx and stomach. SOD consisted of oropharyngeal application only of the same 
antibiotics.
Outcomes: Mortality at day 28 was the primary end point. Monthly point-prevalence studies were performed to 
analyze antibiotic resistance.
Results
A total of 5939 patients were enrolled in the study, with 1990 assigned to standard care, 1904 to SOD, and 2045 to SDD; 
crude mortality in the groups at day 28 was 27.5%, 26.6%, and 26.9%, respectively. In a random-eff ects logistic-regression 
model with age, sex, Acute Physiology and Chronic Health Evaluation (APACHE II) score, intubation status, and medical 
specialty used as covariates, odds ratios for death at day 28 in the SOD and SDD groups, as compared with the standard-
care group, were 0.86 (95% confi dence interval [CI], 0.74 to 0.99) and 0.83 (95% CI, 0.72 to 0.97), respectively.
Conclusions
In an ICU population in which the mortality rate associated with standard care was 27.5% at day 28, the rate was 
reduced by an estimated 3.5 percentage points with SDD and by 2.9 percentage points with SOD. (Controlled Clinical 
Trials number, ISRCTN35176830.)
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Commentary
Intensive care unit (ICU)-acquired infections, such as 
ventilator-associated pneumonia (VAP), are common, 
costly, and associated with increased morbidity and 
mortality. Prophylactic antibiotic regimens, such as 
selective decontamination of the digestive tract (SDD) 
and selective oropharyngeal decontamination (SOD), 
have the potential to reduce VAP and mortality rates. 
SDD consists of intravenous antibiotic administration 
coupled with topical application in the oropharynx and 
stomach. SOD, on the other hand, consists solely of 
topical antibiotic application to the oropharynx. Reduc-
tions in the incidence of respiratory tract infections have 
been demonstrated with both SDD and SOD. Proof of 
mortality reduction with these techniques is lacking due 
to the relatively small size of prior studies. Meta-analyses 
suggest that SDD, but not SOD, reduces mortality [2-5]. 
Enthusiasm regarding use of either of these techniques 
has been tempered by the very real threat of increased 
selection of antibiotic-resistant pathogens.
To determined the eﬀ ectiveness of SDD and SOD in 
intensive care unit patients, de Smet and colleagues 
conducted a large, multicenter, cluster randomized trial 
of these modalities verses standard care in 5939 adult 
ICU patients, 92% of which were mechanically ventilated 
for more than 48 hours, with the remaining subjects 
anticipated to stay in the ICU for more than 72 hours. 
Despite the large size of the study, randomization failed 
to balance important baseline patient characteristics, 
such as severity of illness, presence of mechanical venti-
lation, and post-operative status. Due to these imbalances 
and the need to account for potential cluster eﬀ ects, the 
main results of the study are those of a random-eﬀ ects 
logistic regression model. Crude 28-day mortality rates 
did not diﬀ er between standard care, SOD, and SDD 
groups (27.5%, 26.6%, and 26.9%, p=0.78). After adjusting 
for baseline diﬀ erences, however, both SOD and SDD 
were associated with lower odds of death as compared to 
standard care, with odds ratios of 0.86 (p=0.045) and 0.83 
(p=0.02), respectively. Based on the models, SOD was 
estimated to reduce 28-day mortality by 2.9% (absolute 
risk reduction) and SDD by 3.5%, with corresponding 
numbers need to treat of 34 and 29. Th ere were no short-
term increases in bacterial resistance in surveillance 
cultures or in the detection of C. diﬃ  cile toxin.
Th is is the largest study to date to examine the use of 
SDD and SOD in the ICU. Unfortunately, the failure of 
randomization to balance baseline characteristics and the 
lack of a signiﬁ cant diﬀ erence in crude mortality rates is 
cause for concern. True, regression analysis was used to 
adjust for known diﬀ erences in baseline characteristics, 
but what of those that were unmeasured, and therefore, 
unknown? Perhaps more concerning are issues of 
generalizablity. Th e study population in the Netherlands 
is quite diﬀ erent in terms of microbiologic characteristics 
when compared to other parts of the world, especially the 
United States. For instance, in this study of 5939 patients 
there were only 29 patients with C. diﬃ  cile toxin, 8 
patients with vancomycin-resistant enterococci, and no 
patients with methicillin-resistant S. aureus, which is 
drastically diﬀ erent from many ICUs in the rest of the 
world. Th ough there were no short-term increases in 
bac terial resistance in this study, the eﬀ ect of these 
prophylactic regimens on long-term resistance is un-
known. More recently, the same group of authors 
reported the ecological eﬀ ects of the SOD and SDD 
regimens used in this study on resistant gram-negative 
bacterial colonization in study ICUs [6]. Th ey found that 
SOD and SDD had marked eﬀ ects on the bacterial 
ecology in an ICU, with rising ceftazidime resistance 
prevalence rates in the respiratory tract during the inter-
vention and a considerable rebound eﬀ ect of ceftazidime 
resistance in the intestinal tract after discontinuation of 
SDD. Other studies suggest that in settings with high 
levels of endemic, multidrug-resistant gram-negative 
bacteria [7,8] or methicillin-resistant S. aureus [9], SDD is 
associated with increased selection of such pathogens. 
Importantly, one of the oral antimicrobials used in the 
study, colistin, is one of the last resort antibiotics for 
multidrug resistant Pseudomonas aeruginosa and 
Acineto bacter [3].
Recommendation
Since there were similar mortality reductions with both 
SDD and SOD, SOD may be the preferred modality, at 
least in low-resistance settings since it avoids routinely 
exposing patients to intravenous antibiotics. However, in 
high-resistance settings it is not clear whether either 
modality should be used due to concerns over emerging 
resistance and the lack of adequately powered studies 
demonstrating a morality beneﬁ t in these settings. In 
high-resistance settings, standard VAP precautions  [10], 
such as head-of-bed elevation, sedation interruption, and 
spontaneous breathing trials, and oral antiseptics, such 
as chlorhexidine  [2], may be better options.
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